نتائج البحث - Ning-I Yang

  • يعرض 1 - 6 نتائج من 6
تنقيح النتائج
  1. 1
    Understanding the Epidemiology of Heart Failure to Improve Management Practices: An Asia-Pacific Perspective

    Understanding the Epidemiology of Heart Failure to Improve Management Practices: An Asia-Pacific Perspective حسب Jeyamalar Rajadurai, Hung‐Fat Tse, Chao‐Hung Wang, Ning‐I Yang, Jingmin Zhou, David Sim

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Circulating Klotho levels can predict long-term macrovascular outcomes in type 2 diabetic patients

    Circulating Klotho levels can predict long-term macrovascular outcomes in type 2 diabetic patients حسب Heng‐Chih Pan, Kuei-Mei Chou, Chin‐Chan Lee, Ning‐I Yang, Chiao‐Yin Sun

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study

    Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study حسب Shih‐Chieh Shao, Kai-Cheng Chang, Ming‐Jui Hung, Ning-I Yang, Yuk-Ying Chan, Hui‐Yu Chen, Yea‐Huei Kao Yang, Edward Chia‐Cheng Lai

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Metabolic Disturbances Identified in Plasma Are Associated With Outcomes in Patients With Heart Failure

    Metabolic Disturbances Identified in Plasma Are Associated With Outcomes in Patients With Heart Failure حسب Mei‐Ling Cheng, Chao‐Hung Wang, Ming‐Shi Shiao, Min‐Hui Liu, Yu-Yen Huang, Cheng-Yu Huang, Chun‐Tai Mao, Jui‐Fen Lin, Hung‐Yao Ho, Ning‐I Yang

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease

    The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease حسب Yuan Lin, Te-Hsiung Wang, Ming‐Lung Tsai, Victor Chien‐Chia Wu, Chin-Ju Tseng, Ming‐Shyan Lin, Yanrong Li, Chih‐Hsiang Chang, Tien‐Shin Chou, Tzu‐Hsien Tsai, Ning‐I Yang, Ming‐Jui Hung, Tien‐Hsing Chen

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

    Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial حسب Kim A. Connelly, C. David Mazer, Pankaj Puar, Hwee Teoh, Chao‐Hung Wang, Tamique Mason, Farhad Akhavein, Ching‐Wen Chang, Min‐Hui Liu, Ning‐I Yang, Wei-Siang Chen, Yu‐Hsiang Juan, Erika Opingari, Yaseen Salyani, William Barbour, Aryan Pasricha, Shamon Ahmed, Andrew Kosmopoulos, Raj Verma, Michael Moroney, Ehab Bakbak, Aishwarya Krishnaraj, Deepak L. Bhatt, Javed Butler, Mikhail Kosiborod, Carolyn S.P. Lam, David A. Hess, Otávio R. Coelho‐Filho, Myriam Lafrenière‐Roula, Kevin E. Thorpe, Adrian Quan, Lawrence A. Leiter, Andrew T. Yan, Subodh Verma

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: